InsidersTradesSigma
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by SCHIFF ANDREW N, Director. Director active across 1 company, notably Aclaris Therapeutics, Inc.. Cumulatively, 10 disclosures have been published. Breakdown: 0 buy · 6 sells. Total volume traded: €1.3m. History available since 17 June 2022. The latest transaction was disclosed on 10 November 2022 (Cession). Regulator: SEC (Form 4). All data is free.
10 of 10 declarations
Andrew N. Schiff is a Board Member at Aclaris Therapeutics, Inc., a biopharmaceutical company focused on developing treatments for dermatological diseases. As a board member, he participates in overseeing the company's strategies and making key decisions. Andrew brings expertise in biotechnology and drug development.